3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Motor Activity
32
Breast Neoplasms
21
Neoplasms
17
Prostatic Neoplasms
11
Obesity
8
Colorectal Neoplasms
6
Sarcopenia
5
Pancreatic Neoplasms
5
Lung Neoplasms
5
Polycystic Ovary Syndrome
4
Head and Neck Neoplasms
4
Signs and Symptoms
3
Multiple Myeloma
3
Lymphedema
3
Inflammation
3
Fatigue
3
Diabetes Mellitus, Type 2
3
Colonic Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Pharyngeal Neoplasms
2
Overweight
2
Osteoporosis, Postmenopausal
2
Osteoporosis
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Laryngeal Neoplasms
2
Insulin Resistance
2
Endometrial Neoplasms
2
Interventions
Cyclophosphamide
57
fludarabine phosphate
48
Tacrolimus
39
Peripheral Blood Stem Cell Transplantation
37
Busulfan
36
Mycophenolic Acid
34
Whole-Body Irradiation
31
Antilymphocyte Serum
28
Methotrexate
26
Cyclosporine
25
fludarabine
23
Melphalan
18
Filgrastim
15
Radiotherapy
14
thymoglobulin
12
ruxolitinib
12
Methylprednisolone
12
Cord Blood Stem Cell Transplantation
12
Stem Cell Transplantation
11
Sirolimus
11
Psychiatric Rehabilitation
9
Flow Cytometry
9
Etoposide
9
Specimen Handling
7
Granulocyte Colony-Stimulating Factor
7
merphos
6
Therapeutics
6
Decitabine
6
Cyclosporins
6
Azacitidine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Primary Myelofibrosis
×
Resistance Training
×
Clear all
NCT07518940
2026-04-09
ENERGIA
University of Turin, Italy
Phase NA
Not yet recruiting
25 enrolled